Related Experiment Video
Updated: Feb 1, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Myocardial fibrosis predicts adverse outcome after MitraClip implantation
Juliëtte F Velu1, Alexander Hirsch2, S M Boekholdt1
1Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Heart Center, University of Amsterdam, Amsterdam, The Netherlands.
Background:
High-risk patients with mitral regurgitation (MR) may be treated by a percutaneous mitral valve repair with the MitraClip, but identification of patients who may benefit remains difficult. We aimed to determine whether myocardial fibrosis predicts outcome in MR patients undergoing MitraClip implantation and is beneficial in clinical decision making.
Methods:
Preprocedural to the MitraClip implantation, myocardial fibrosis was analyzed with cardiovascular magnetic resonance (CMR) through late gadolinium enhancement. The CMR data were core-lab adjudicated measured before the MitraClip implantation. Adverse outcome was defined as New York Heart Association (NYHA) class III or IV after 1 month or death within 1 month after the MitraClip implantation.
Results:
In total, 23 patients underwent preprocedural CMR, mean age 80 ± 9 years, 45% male, 64% atrial fibrillation and 73% NYHA class III or IV at baseline. Myocardial fibrosis was present in 55% of the patients with degenerative MR and in 64% of the patients with functional MR. An adverse outcome occurred in 69% of the patients with myocardial fibrosis and in 11% of the patients without myocardial fibrosis (P = 0.01).
Conclusions:
Our hypothesis-generating study showed that the presence of myocardial fibrosis predicts adverse outcome in patients undergoing MitraClip implantation. After confirmation with larger sample size, identification of myocardial fibrosis might contribute to assess prognosis and to clinical decision making.
Insights
Myocardial fibrosis, detected via cardiovascular magnetic resonance, predicts adverse outcomes in high-risk mitral regurgitation patients receiving the MitraClip device. This finding may aid clinical decision-making for these complex cases.
Area of Science:
- Cardiology
- Medical Imaging
- Interventional Cardiology
Background:
- High-risk patients with mitral regurgitation (MR) often undergo percutaneous mitral valve repair using the MitraClip.
- Identifying which patients will benefit from MitraClip implantation remains challenging.
Purpose of the Study:
- To investigate if myocardial fibrosis predicts outcomes in MR patients treated with MitraClip.
- To assess the utility of myocardial fibrosis detection in clinical decision-making for MitraClip procedures.
Main Methods:
- Preprocedural cardiovascular magnetic resonance (CMR) with late gadolinium enhancement was used to analyze myocardial fibrosis.
- Adverse outcome was defined as New York Heart Association (NYHA) class III-IV or death within one month post-MitraClip implantation.
Main Results:
- Myocardial fibrosis was identified in a significant proportion of patients (55% degenerative MR, 64% functional MR).
- Patients with myocardial fibrosis had a substantially higher rate of adverse outcomes (69%) compared to those without (11%, P=0.01).
Conclusions:
- The presence of myocardial fibrosis is a predictor of adverse outcomes in patients undergoing MitraClip implantation for MR.
- Further studies with larger sample sizes are needed to confirm these findings and integrate myocardial fibrosis assessment into clinical decision-making and prognosis evaluation.
Related Concept Videos
Predicting Reaction Outcomes
Predicting Molecular Geometry
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.

